Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Combination Antibody Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Combination Antibody Therapymarket, defines the market attractiveness level of Combination Antibody Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Combination Antibody Therapy industry, describes the types of Combination Antibody Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Combination Antibody Therapy market and the development prospects and opportunities of Combination Antibody Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Combination Antibody Therapy market in Chapter 13.
By Player:
Amgen
Novartis
Celgene
Eli Lilly
Biogen
Genmab
Sanofi
Bristol-Myers Squibb
Roche Holdings
Seattle Genetics
By Type:
Chemotherapy/Antibody
Antibody/Antibody
Conjugated Antibodies
Bispecific Antibodies
By End-User:
Hospitals
Cancer Research Institutes
Clinics
ASCs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Combination Antibody Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Combination Antibody Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Combination Antibody Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Combination Antibody Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Combination Antibody Therapy Market Analysis and Outlook to 2022
-
7.1 Global Combination Antibody Therapy Consumption (2017-2022)
-
7.2 United States Combination Antibody Therapy Consumption (2017-2022)
-
7.3 Europe Combination Antibody Therapy Consumption (2017-2022)
-
7.4 China Combination Antibody Therapy Consumption (2017-2022)
-
7.5 Japan Combination Antibody Therapy Consumption (2017-2022)
-
7.6 India Combination Antibody Therapy Consumption (2017-2022)
-
7.7 South Korea Combination Antibody Therapy Consumption (2017-2022)
8 Region and Country-wise Combination Antibody Therapy Market Analysis and Outlook to 2028
-
8.1 Global Combination Antibody Therapy Consumption Forecast (2022-2028)
-
8.2 United States Combination Antibody Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Combination Antibody Therapy Consumption Forecast (2022-2028)
-
8.4 China Combination Antibody Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Combination Antibody Therapy Consumption Forecast (2022-2028)
-
8.6 India Combination Antibody Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Combination Antibody Therapy Consumption Forecast (2022-2028)
9 Global Combination Antibody Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Combination Antibody Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy/Antibody Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antibody/Antibody Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Conjugated Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Bispecific Antibodies Consumption and Growth Rate (2017-2022)
-
9.2 Global Combination Antibody Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global ASCs Consumption and Growth Rate (2017-2022)
10 Global Combination Antibody Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Combination Antibody Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy/Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antibody/Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Conjugated Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Bispecific Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Combination Antibody Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global ASCs Consumption Forecast and Growth Rate (2022-2028)
11 Global Combination Antibody Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Combination Antibody Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Combination Antibody Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Combination Antibody Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Combination Antibody Therapy Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Combination Antibody Therapy Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Combination Antibody Therapy Product and Service
-
14.3 Celgene
-
14.3.1 Celgene Company Details
-
14.3.2 Celgene Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Combination Antibody Therapy Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly Combination Antibody Therapy Product and Service
-
14.5 Biogen
-
14.5.1 Biogen Company Details
-
14.5.2 Biogen Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biogen Combination Antibody Therapy Product and Service
-
14.6 Genmab
-
14.6.1 Genmab Company Details
-
14.6.2 Genmab Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Genmab Combination Antibody Therapy Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Combination Antibody Therapy Product and Service
-
14.8 Bristol-Myers Squibb
-
14.8.1 Bristol-Myers Squibb Company Details
-
14.8.2 Bristol-Myers Squibb Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Combination Antibody Therapy Product and Service
-
14.9 Roche Holdings
-
14.9.1 Roche Holdings Company Details
-
14.9.2 Roche Holdings Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Roche Holdings Combination Antibody Therapy Product and Service
-
14.10 Seattle Genetics
-
14.10.1 Seattle Genetics Company Details
-
14.10.2 Seattle Genetics Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Seattle Genetics Combination Antibody Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Combination Antibody Therapy
-
Figure Combination Antibody Therapy Picture
-
Table Global Combination Antibody Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Combination Antibody Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Combination Antibody Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Combination Antibody Therapy Consumption by Country (2017-2022)
-
Figure United States Combination Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Combination Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Combination Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Combination Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Combination Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Combination Antibody Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Antibody Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Combination Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Combination Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Combination Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Combination Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Combination Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Combination Antibody Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy/Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody/Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Conjugated Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Bispecific Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global ASCs Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy/Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibody/Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Conjugated Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bispecific Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ASCs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Combination Antibody Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Combination Antibody Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Combination Antibody Therapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Combination Antibody Therapy Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Combination Antibody Therapy Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Combination Antibody Therapy Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Combination Antibody Therapy Product and Service
-
Table Genmab (Foundation Year, Company Profile and etc.)
-
Table Genmab Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genmab Combination Antibody Therapy Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Combination Antibody Therapy Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Combination Antibody Therapy Product and Service
-
Table Roche Holdings (Foundation Year, Company Profile and etc.)
-
Table Roche Holdings Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holdings Combination Antibody Therapy Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Combination Antibody Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Combination Antibody Therapy Product and Service
-
